# Lattice-Informed Formalism (LATIFF)

## Theoretical Foundation

The SAEM framework treats cancer within a lattice-theoretic structure where metabolic states form a **partially ordered set** under Kramers escape dynamics. The lattice ordering is defined by basin depth: deeper basins (harder to escape) dominate shallower ones.

### Definitions

| Symbol | Meaning |
|--------|---------|
| **A** | Generator matrix (10×10) governing metabolic dynamics dx/dt = Ax |
| **μ(A)** | Basin curvature — minimum eigenvalue modulus of A (attractor depth) |
| **κ** | Kramers escape rate: κ ∝ exp(-μ/σ²) where σ is noise scale |
| **δA** | Therapeutic correction: A_treated = A_cancer + Σ δA_drug |
| **S(i,j)** | Synergy coefficient between drugs i,j (Bliss independence) |
| **F_net** | Net immune force vector (CD8 + NK − Treg suppression) |
| **R(t)** | Resistance decay factor: R(t) = exp(−t/τ_resistance) |

### Lattice Structure

The set of cancer metabolic states forms a **join-semilattice** where:

```
Healthy ≤ NSCLC ≤ Melanoma ≤ CRC ≤ TNBC ≤ GBM ≤ HCC ≤ PDAC
```

The ordering reflects attractor depth (seriousness), where PDAC has the deepest basin and NSCLC the shallowest. The join operation (∨) corresponds to the most resistant combined state:

```
TNBC ∨ PDAC = PDAC  (PDAC dominates due to deeper basin + desmoplasia)
```

### The Geometric Achievement Protocol as Lattice Descent

The 3-phase protocol is a sequence of lattice operations:

1. **Phase 1 (Flatten)**: Apply curvature reducers (DCA, Metformin, 2-DG, CB-839)
   → Reduces μ(A), lowering the state in the curvature lattice

2. **Phase 2 (Heat)**: Entropic drivers (hyperthermia, Vitamin C) inject noise σ
   → Increases Kramers escape rate κ ∝ exp(-μ/σ²) exponentially

3. **Phase 3 (Push)**: Immune force F_net pushes along escape direction
   → Trajectory crosses the basin boundary toward healthy attractor

### Multi-Compartment Extension (Project Confluence)

The lattice is extended to spatial compartments:

```
State = (state_core, state_rim, state_stroma)
μ_effective = Σ_c  w_c · μ_c    (volume-weighted curvature)
```

Drug penetration adds a spatial dimension to the lattice ordering:
- Core (hypoxic, low drug access) is the lattice maximum
- Rim (normoxic, high drug access) is the lattice minimum
- Stroma (intermediate) bridges the two

### Resistance as Lattice Ascent

Resistance evolution moves the system UP the lattice (toward deeper basins):

```
A_resistant(t) = A_cancer + Σ_drugs  R_drug(t) · δA_drug
```

where R_drug(t) is the resistance factor from:
- Efflux pumps: P-gp induction reduces effective [drug]
- Target mutations: binding site changes reduce δA_drug magnitude
- Metabolic rewiring: cancer adapts generator to counter drug effects
- Clonal selection: resistant subclones outcompete sensitive cells

Drug holidays enable **lattice re-descent**: resistance factors decay during treatment breaks, restoring drug efficacy.

### Patient Stratification as Lattice Position

Each patient's metabolic state maps to a position in the lattice:

```
Patient_i → (A_i, immune_status_i, barrier_i) → seriousness_i ∈ [0, 1]
```

Protocol adaptation = choosing the right lattice descent path for each starting position.

## Connection to Remisov's Coherence Theory

The lattice formalism unifies with Remisov's coherence framework:
- **Coherence score** = measure of attractor health (distance from lattice minimum)
- **Coherence deficit** = Frobenius norm ‖A_cancer − A_healthy‖_F (lattice distance)
- **Therapeutic goal** = minimize coherence deficit via δA corrections
- **Cure** = reaching coherence score > threshold (lattice minimum = healthy state)
